Syndax Pharmaceuticals, Inc.
SNDX
$20.07
-$0.35-1.69%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -30.03% | -29.03% | 11.76% | 8.43% | 16.51% |
| Total Receivables | 182.53% | 406.75% | 818.23% | 243.91% | 183.18% |
| Inventory | 495.41% | 1,542.36% | -- | -- | -- |
| Prepaid Expenses | 2.26% | 18.05% | 17.31% | 27.80% | -0.52% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 322.12% | 99.18% | 346.33% | 2,274.19% | 548.19% |
| Total Current Assets | -14.14% | -12.43% | 27.73% | 19.19% | 20.90% |
|
|
|||||
| Total Current Assets | -14.14% | -12.43% | 27.73% | 19.19% | 20.90% |
| Net Property, Plant & Equipment | -22.88% | -24.68% | 111.51% | 62.57% | 44.31% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -53.00% | -53.00% | 0.00% | -41.82% | -53.33% |
| Total Assets | -26.23% | -26.92% | 29.59% | 24.99% | 17.99% |
|
|
|||||
| Total Accounts Payable | 7.92% | 42.61% | 182.28% | 50.01% | 14.05% |
| Total Accrued Expenses | 28.61% | 71.50% | 59.69% | 182.94% | 77.01% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -96.64% | -96.25% | 2,629.58% | 1,892.45% | 1,278.84% |
| Total Finance Division Other Current Liabilities | -90.05% | -96.33% | -89.59% | -81.40% | 48.01% |
| Total Other Current Liabilities | -90.05% | -96.33% | -89.59% | -81.40% | 48.01% |
| Total Current Liabilities | -8.86% | 16.00% | 92.31% | 166.03% | 86.11% |
|
|
|||||
| Total Current Liabilities | -8.86% | 16.00% | 92.31% | 166.03% | 86.11% |
| Long-Term Debt | 4.34% | 3.72% | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -37.58% | -33.40% | 59,400.00% | 867.15% | 335.03% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.27% | 6.50% | 634.88% | 929.65% | 732.34% |
|
|
|||||
| Common Stock & APIC | 4.63% | 4.08% | 4.05% | 3.85% | 3.62% |
| Retained Earnings | -18.63% | -23.37% | -27.65% | -32.12% | -33.98% |
| Treasury Stock & Other | -97.91% | 177.30% | 41.51% | 134.88% | 169.71% |
| Total Common Equity | -80.65% | -77.57% | -68.50% | -63.76% | -56.28% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -80.65% | -77.57% | -68.50% | -63.76% | -56.28% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -80.65% | -77.57% | -68.50% | -63.76% | -56.28% |
|
|
|||||